Loading...
•
Dec 31, 2021
Globus Medical Q4 2021 Earnings Report
Globus Medical reported an increase in worldwide net sales and a decrease in GAAP net income for the fourth quarter of 2021.
Key Takeaways
Globus Medical's Q4 2021 results showed a 7.1% increase in worldwide net sales compared to Q4 2020, reaching $250.0 million. GAAP net income decreased by 71.5% to $15.1 million, while non-GAAP diluted EPS was $0.49. The company's Enabling Technology momentum was driven by the clinical superiority of ExcelsiusGPS®, with a record $25 million in revenue.
Worldwide net sales increased by 7.1% to $250.0 million compared to Q4 2020.
GAAP net income for the quarter was $15.1 million.
GAAP diluted EPS was $0.14, and non-GAAP diluted EPS was $0.49.
Non-GAAP adjusted EBITDA was $85.2 million, representing 34.1% of net sales.
Globus Medical
Globus Medical
Globus Medical Revenue by Segment
Globus Medical Revenue by Geographic Location
Revenue by Segment
Musculoskeletal Solutions Revenue
CapyFin.comEnabling Technologies Revenue
CapyFin.comRevenue by Geographic Location
United States Revenue
CapyFin.comInternational Revenue
CapyFin.com Forward Guidance
The Company announced full year 2022 guidance with expected net sales of $1.025 billion and non-GAAP diluted earnings per share of $2.10.
Positive Outlook
- Expected net sales of $1.025 billion for full year 2022.
- Non-GAAP diluted earnings per share of $2.10 for full year 2022.
Revenue & Expenses
Visualization of income flow from segment revenue to net income